Investment type
ICICI Pru Nifty Pharma Index Fund-Dir (G) is a mutual fund under the Index Funds category, managed by ICICI Prudential Mutual Fund. It was launched on 22 Jun 1993, and has been active for over 32 years. As of 31 Mar 2025 the fund manages assets worth ₹84 Crores. The expense ratio is 0.37%.
This fund generated returns of 11.77% in the last 1 year. Since its inception, it has provided an average annual return of 22.76%.
The fund's investments are mainly concentrated in sectors like Pharmaceuticals & Biotech and Debt.
The top five holdings in this fund include prominent companies such as Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs and Lupin.
The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Index funds are generally low-risk as they spread investments across an entire market index, reducing the impact of individual stock volatility.
Yes, if you’re looking for a low-cost way to invest in the market and are comfortable with moderate returns that match market trends.
Ideally, you should stay invested for the long term, as index funds perform best over extended periods.
Yes, index funds are open-ended, so you can withdraw at any time, but it's best to hold them long-term.
Index funds usually have low expense ratios due to passive management, often ranging from 0.1% to 0.5%.
By joining our referral program, you agree to our Terms of Use
Powered by Viral Loops.
Invest as little as Re.1 in US Stocks
